Xu L, Shen T, Li Y, Wu X
Clin Rev Allergy Immunol. 2025; 68(1):29.
PMID: 40085180
DOI: 10.1007/s12016-025-09041-6.
Yan Y, Fu J
Front Oncol. 2025; 15:1522157.
PMID: 40018408
PMC: 11864947.
DOI: 10.3389/fonc.2025.1522157.
Xie X, Fang Z, Zhang H, Wang Z, Li J, Jia Y
EXCLI J. 2025; 24:113-150.
PMID: 39967906
PMC: 11830918.
DOI: 10.17179/excli2024-7935.
Li P, Lin Y, Ma H, Zhang J, Zhang Q, Yan R
Cell Death Discov. 2025; 11(1):43.
PMID: 39904996
PMC: 11794895.
DOI: 10.1038/s41420-025-02324-z.
Wang H, Zhang Z, Han C, Jiang P, Xu J, Han Y
Nat Cell Biol. 2025; 27(2):246-261.
PMID: 39890952
DOI: 10.1038/s41556-024-01593-7.
mA modification: a new avenue for anti-cancer therapy.
Bai Y, Li K, Peng J, Yi C
Life Med. 2025; 2(1):lnad008.
PMID: 39872957
PMC: 11749794.
DOI: 10.1093/lifemedi/lnad008.
The interplay between RNA m6A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review.
Cheng Y, Shang Y, Zhang S, Fan S
Cancer Biol Med. 2025; 21(12.
PMID: 39831771
PMC: 11745087.
DOI: 10.20892/j.issn.2095-3941.2024.0415.
Epigenetic Mechanisms in Osteoporosis: Exploring the Power of mA RNA Modification.
Tian S, Song Y, Guo L, Zhao H, Bai M, Miao M
J Cell Mol Med. 2025; 29(1):e70344.
PMID: 39779466
PMC: 11710941.
DOI: 10.1111/jcmm.70344.
METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patients.
Zhao J, Sun R, Zhi L, Guo D, Ling S, Liang X
Future Oncol. 2024; 21(3):331-340.
PMID: 39706798
PMC: 11792863.
DOI: 10.1080/14796694.2024.2442296.
Dust mite antigens endow dendritic cells with the capacity to induce a Th2 response by regulating their methylation profiles.
Zhang X, Zheng H, Dong Y, Zhang H, Liu L, Zhang Y
Cell Commun Signal. 2024; 22(1):606.
PMID: 39695662
PMC: 11656822.
DOI: 10.1186/s12964-024-01986-z.
Role of N6-methyladenosine methylation in nasopharyngeal carcinoma: current insights and future prospective.
Zhao Y, Li J, Dian M, Bie Y, Peng Z, Zhou Y
Cell Death Discov. 2024; 10(1):490.
PMID: 39695216
PMC: 11655975.
DOI: 10.1038/s41420-024-02266-y.
The role of N6-methyladenosine modification in tumor angiogenesis.
Qin L, Zeng X, Qiu X, Chen X, Liu S
Front Oncol. 2024; 14:1467850.
PMID: 39691597
PMC: 11649548.
DOI: 10.3389/fonc.2024.1467850.
The Ptch/SPOUT1 methyltransferase deposits an mU modification on 28 rRNA for normal ribosomal function in flies and humans.
Chen J, Bai Y, Huang Y, Cui M, Wang Y, Gu Z
Sci Adv. 2024; 10(50):eadr1743.
PMID: 39671501
PMC: 11641110.
DOI: 10.1126/sciadv.adr1743.
Regulation and application of mA modification in tumor immunity.
Xiong Q, Zhang Y, Zheng Y, Zhu Q
Sci China Life Sci. 2024; .
PMID: 39648245
DOI: 10.1007/s11427-024-2648-0.
Interplay between epigenetics, senescence and cellular redox metabolism in cancer and its therapeutic implications.
Balamurli G, Liew A, Tee W, Pervaiz S
Redox Biol. 2024; 78:103441.
PMID: 39612910
PMC: 11629570.
DOI: 10.1016/j.redox.2024.103441.
RNA modifications: emerging players in the regulation of reproduction and development.
Wen J, Zhu Q, Liu Y, Gou L
Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):33-58.
PMID: 39574165
PMC: 11802351.
DOI: 10.3724/abbs.2024201.
Insights into the role of N6-methyladenosine (m6A) in plant-virus interactions.
Secco N, Sheikh A, Hirt H
J Virol. 2024; 99(1):e0159824.
PMID: 39570081
PMC: 11784248.
DOI: 10.1128/jvi.01598-24.
Global Co-regulatory Cross Talk Between mA and mC RNA Methylation Systems Coordinate Cellular Responses and Brain Disease Pathways.
Orji O, Stones J, Rajani S, Markus R, Demirbugen Oz M, Knight H
Mol Neurobiol. 2024; 62(4):5006-5021.
PMID: 39499421
PMC: 11880056.
DOI: 10.1007/s12035-024-04555-0.
Targeting methyltransferase-like 5-mediated sphingomyelin metabolism: A novel therapeutic approach in gastric cancer.
Zhang J, Yuan C, Dang S
World J Gastrointest Oncol. 2024; 16(10):4060-4063.
PMID: 39473944
PMC: 11514671.
DOI: 10.4251/wjgo.v16.i10.4060.
Interplay of RNA mA Modification-Related Geneset in Pan-Cancer.
Zhang B, Hao Y, Liu H, Wu J, Lu L, Wang X
Biomedicines. 2024; 12(10).
PMID: 39457524
PMC: 11504890.
DOI: 10.3390/biomedicines12102211.